Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark Ruchika Sharma10 Dec 2025 2:48 PM ISTBasel: Roche has announced the CE Mark for its cobas BV/CV (Bacterial Vaginosis/Candida Vaginitis) assay to accurately identify specific bacteria and...
Roche Gazyva/Gazyvaro approved by European Commission for adults with active lupus nephritis Ruchika Sharma9 Dec 2025 4:30 PM ISTBasel: Roche has announced that the European Commission has approved Gazyva/Gazyvaro (obinutuzumab) in combination with mycophenolate mofetil (MMF)...
USFDA clears Roche 15-minute Bordetella PCR Test Ruchika Sharma2 Dec 2025 12:35 PM ISTBasel: Roche has announced that its first point-of-care test for the diagnosis of whooping cough (pertussis) and other Bordetella infections, has...
Roche Lunsumio subcutaneous secures European Commission approval for refractory follicular lymphoma Ruchika Sharma19 Nov 2025 10:30 AM ISTBasel: Roche has announced that the European Commission has granted conditional marketing authorisation of Lunsumio (mosunetuzumab) subcutaneous...
Phase III data for Gazyva/Gazyvaro show significant reduction in disease activity for systemic lupus erythematosus: Roche Ruchika Sharma3 Nov 2025 10:30 AM ISTBasel: Roche has announced statistically significant and clinically meaningful results from the phase III ALLEGORY study of Gazyva/Gazyvaro...
Roche gets CE mark for Elecsys Dengue Ag test to diagnose dengue Ruchika Sharma2 Nov 2025 3:45 PM ISTBasel: Roche has announced that it has received CE mark for its Elecsys Dengue Ag test - a high-throughput, fully automated immunoassay to be...
Roche appoints Nina Schwab-Hautzinger as Head of Group Communications Ruchika Sharma26 Oct 2025 2:45 PM ISTBasel: Roche has announced that Nina Schwab-Hautzinger has been appointed Head of Group Communications and a member of the enlarged Corporate...
USFDA nod to Roche Gazyva/Gazyvaro for lupus nephritis Ruchika Sharma22 Oct 2025 6:37 PM ISTBasel: Roche has announced that the US Food and Drug Administration (FDA) has approved Gazyva/Gazyvaro (obinutuzumab) for the treatment of adult...
Natco Gets SC Nod to Launch Generic Risdiplam at 80% Lower Price, Roche Appeal Dismissed Parthika Patel18 Oct 2025 7:14 PM ISTNew Delhi: The Supreme Court has given the go-ahead to Natco Pharma for launching its generic version of Risdiplam in India, dismissing the appeal...
Roche Moves SC Against Delhi HC Nod to Natco's Rs 15,900 Generic Risdiplam for Spinal Atrophy Parthika Patel16 Oct 2025 7:44 PM ISTNew Delhi: In a major escalation of the patent battle over a life-saving rare disease drug, Swiss pharmaceutical giant F. Hoffmann-La Roche AG has...
Roche gets USFDA clearance for Elecsys pTau181 test for Alzheimer's disease Ruchika Sharma15 Oct 2025 7:02 PM ISTIndianapolis: Roche has announced that the United States Food and Drug Administration (FDA) has cleared its Elecsys pTau181 test, the...
Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy Susmita Roy11 Oct 2025 9:41 PM ISTNew Delhi: The Delhi High Court has dismissed an appeal filed by Swiss drug major F. Hoffmann-La Roche AG and its Indian arm, challenging the order of...
